Bioxcel Therapeutics, Inc. · NASDAQ:BTAI

Armistice Capital, LLC reported a 7.05% stake in Bioxcel Therapeutics, Inc. (Schedule 13G)

Event Mar 31, 2026 · Filed May 15, 2026

Armistice Capital, LLC reported a 7.05% stake in Bioxcel Therapeutics, Inc., 1,910,076 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G).

Stake
7.05%
Shares
1,910,076
Intent
Passive
What changed
Crossed above 5%
Filed together
2 holders

The filing in full

HolderStakeShares
Armistice Capital, LLC7.05%1,910,076
Steven Boyd7.05%1,910,076

Source

View original at SEC

Related